BAYS F BARRY 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Jan 26, 2023
Insider Transaction Report
Form 4
BAYS F BARRY
Director
Transactions
- Sale
Common Stock
2023-01-24$26.03/sh−25,921$674,744→ 1,365,336 total - Sale
Common Stock
2023-01-25$25.73/sh−7,255$186,659→ 1,337,614 total - Sale
Common Stock
2023-01-25$25.28/sh−20,467$517,441→ 1,344,869 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.7700 to $26.3700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.6600 to $25.6500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.6600 to $25.8100 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.